Antihypertensives generates an estimated $0/month in revenue from 0 downloads/month on the App Store, according to AppCurrents estimates (updated 2026-08-02).
| Est. revenue / month | $0 |
|---|---|
| Est. downloads / month | 0 |
| Estimate confidence | low |
| Pricing | Free + IAP |
| Rating | 0.00 ★ (0 ratings) |
| Category | Medical |
| Released | 29.04.2026 |
| App last updated | 03.06.2026 |
| Platform | iOS |
Modeled monthly estimate · rating velocity · low confidence
About
Antihypertensives — complete prescribing reference for antihypertensive drug classes, based on NICE NG136 and ESC/ESH 2023 guidelines. FREE TO TRY — no purchase needed: - ACE Inhibitors — ramipril, lisinopril, perindopril, doses, monitoring, side effects - Calcium Channel Blockers — amlodipine, felodipine, diltiazem, mechanism FULL ACCESS — £9.99 one-time purchase: Unlocks all sections including…
Trends & analysis
Chart rank trend
US · overallWhy it's surfacing
Scout 21Ratings & velocity
★ 0 in windowGeographic reach
best rank · 0 storefrontsRevenue & downloads trend
monthly estimateIn-app purchases
1 tiersUpdate history
1 update tracked- v1.0.22mo ago
Pricing now displays correctly in your local currency. Various improvements and fixes for a smoother experience.
Antihypertensives — FAQ
How many downloads does Antihypertensives get?
Antihypertensives sees an estimated 0 downloads per month on the App Store, per AppCurrents modeling.
Is Antihypertensives free?
Antihypertensives is free to download on the App Store, monetizing through in-app purchases.
When was Antihypertensives released?
Antihypertensives launched on the App Store on 29.04.2026. Its latest version shipped 03.06.2026.
